Content by Keyword: Substance Abuse and Mental Health

  • Home
  • Substance Abuse and Mental Hea...
  • print
  • email
  • twitter
  • compact
Basic report
Development and Testing of Behavioral Health

Development and Testing of Behavioral Health Quality Measures for Health Plans: Final Report

Jonathan Brown, Sarah Hudson Scholle, Sarah Croake, Miriam Rosenau, Junquing Liu, Nathan Darter, Kelsey Farson Gray, Menolly Hart, Bonnie Harvey, Rita Lewis, Dean Miller, Suzanne Morton, Milesh Patel, and Christine Ranshous Mathematica Policy Research Printer Friendly Version in PDF Format (98 PDF pages)
PDF report
Development and Testing of Behavioral Health

Development and Testing of Behavioral Health Quality Measures for Health Plans: Final Report

Many people with behavioral health disorders receive suboptimal care and suffer poor health outcomes, including premature death. States, health plans, providers, and other stakeholders need a strong set of measures targeting this population to improve the quality of their care. In this project, we developed and tested measures reported by health p
  • BHQMfr.pdf
    export-csvPDF
Report page
PROJECT INFORMATION AND ADDITIONAL REPORTS

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Project Information and Additional Reports

DEVELOPMENT AND TESTING OF BEHAVIORAL HEALTH QUALITY MEASURES
Report page
REFERENCES

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. References

American Society of Addiction Medicine (ASAM). "Opioid Addiction Disease 2015 Facts and Figures." Available at http://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf .
Report page
F. SUMMARY

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. F. Summary

The guidelines provide recommendations on the use of MAT across treatment phases with an emphasis on the maintenance phase. Most of the guidelines were developed based upon expert opinion and scientific literature. Some guidelines focus on special populations and over half mention psychosocial treatment. The strength of the recommendation varies f
Report page
E. SUMMARY OF MEDICATION-ASSISTED TREATMENT

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. E. Summary of Medication-assisted Treatment Quality Measures

TABLE 3 . MAT for Opioid Use Measures Measure Denominator Numerator
Report page
D. VARIATION IN KEY FEATURES OF MEDICATION-

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. D. Variation in Key Features of Medication-assisted Treatment Clinical Guidelines

Stages of Treatment . Both opioid and alcohol use MAT guidelines tend to focus on stages of treatment -- assessment, withdrawal management (also referred to as detoxification), and maintenance -- whereby the recommended dosage of medication and frequency and intensity of MAT vary with the stage of treatment and the client's needs.
Report page
C. SUMMARY OF MEDICATION-ASSISTED TREATMENT

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. C. Summary of Medication-assisted Treatment

TABLE 1 . Summary of MAT Guidelines for Opioid Use Guideline Name (publication year) (appendix table #) Setting Stage(s) of
Report page
B. APPROACH TO REVIEW

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. B. Approach to Review

Even though the roadmap focuses on MAT for opioid use, we recognize that clinical guidelines and measures related to MAT for alcohol and other SUDs could be useful to guide the approach to developing and implementing MAT measures for opioid use. As such, we searched for and reviewed clinical guidelines that include MAT for opioid and alcohol use p
Report page
A. INTRODUCTION

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. A. Introduction

Opioid overdoses claim 17,000 American lives annually (ASAM 2015). Deaths by opioid overdose have nearly quadrupled from 1999 to 2013 (CDC 2015). Nearly 2.5 million Americans are currently at risk for overdoses -- 1.9 million are opioid-dependent, and 517,000 are addicted to heroin (ASAM 2015). In response to the growing opioid epidemic, the U.S.
Report page
ACRONYMS

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Acronyms

The following acronyms are mentioned in this report and/or appendices.
Report page
APPENDIX C. ALCOHOL USE: MEDICATION-ASSISTED

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Appendix C. Alcohol Use: Medication-assisted Treatment and Other Related Measures

TABLE C.1 . Alcohol Use: MAT and Other Related Measures Measure Denominator Numerator
Report page
APPENDIX B. MEDICATION-ASSISTED TREATMENT FOR

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Appendix B. Medication-assisted Treatment for Alcohol Use Clinical Guidelines: Verbatium Excerpts From Relevant Guideline Sections

LIST OF TABLES TABLE B.1 : SAMHSA and NIAAA: Brief Guide to Medication for the Treatment of Alcohol Use Disorder TABLE B.2 : NICE: Technology Appraisal Guidance of Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence TABLE B.3 : WHO: Guidelines for the Identification and Management of Substance Use and SUD in Preg
Report page
APPENDIX D. SUBSTANCE USE: MEDICATION-ASSISTED

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Appendix D. Substance Use: Medication-assisted Treatment and Other Related Measures

TABLE D.1. Substance Use: MAT and Other Related Measures Measure Denominator Numerator
Report page
APPENDIX A. MEDICATION-ASSISTED TREATMENT FOR

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Appendix A. Medication-assisted Treatment for Opioid Use Clinical Guidelines: Excerpts From Relevant Sections

LIST OF TABLES TABLE A.1 : Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process TABLE A.2 : Institute of Obstetricians and Gynecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Care Health Service Executive: Methadone Prescribing and Admini
Report page
ABSTRACT

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Abstract

Summary : In response to the growing opioid epidemic, the U.S. Department of Health and Human Services (HHS) announced a three-pronged initiative in March 2015 to: (1) improve opioid prescribing practices; (2) increase access to naloxone for overdose management; and (3) expand medication-assisted treatment (MAT) to reduce opioid dependence.
Report page
ACKNOWLEDGMENTS

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Acknowledgments

Mathematica Policy Research prepared this review under contract to the Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services (HHS) (HHSP23320100019WI/HHSP23337001T). Additional funding was provided by the HHS Substance Abuse and Mental Health Services Administration (SAMHSA). The authors
Report
Review of Medication-Assisted Treatment

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use

Stefanie Pietras, Melissa Azur and Jonathan Brown Mathematica Policy Research ABSTRACT
  • MATguidelines.pdf
    export-csvPDF
PDF report
Review of Medication-Assisted Treatment

Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use

In response to the growing opioid epidemic, HHS announced a three-pronged initiative in March 2015 to: (1) improve opioid prescribing practices; (2) increase access to naloxone for overdose management; and (3) expand medication-assisted treatment (MAT) to reduce opioid dependence. In support of the initiative, ASPE contracted with Mathematica Poli
  • MATguidelines.pdf
    export-csvPDF
PDF report
Benefits of Medicaid Expansion for Behavioral

Benefits of Medicaid Expansion for Behavioral Health

Across the country, state and local officials are increasingly focused on improving health outcomes for people living with mental illness or substance use disorders. This brief analyzes national data on behavioral health and reviews published research focused on how Medicaid expansion under the Affordable Care Act advances the goal of improving tr
  • BHMedicaidExpansion.pdf
    export-csvPDF

Pages

Form Approved OMB# 0990-0379 Exp. Date 9/30/2020